Biofrontera (BFRI) Profit After Tax (2020 - 2026)
Biofrontera (BFRI) posted quarterly Profit After Tax of $5.6 million for Q4 2025, up 504.01% year-over-year from $933757.1 in Q4 2024, and up 184.82% quarter-over-quarter from -$6.6 million in Q3 2025.
Biofrontera (BFRI) Profit After Tax (2020 - 2026) Analysis & Trends
Biofrontera's Profit After Tax history runs 6 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- In Q4 2025, Profit After Tax rose 504.01% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at -$10.5 million (up 40.67% YoY), while the FY2025 annual figure was -$10.5 million, up 40.67% from the prior year.
- Profit After Tax for Q4 2025 stood at $5.6 million, up from -$6.6 million in the prior quarter.
- The five-year high for Profit After Tax was $5.6 million in Q4 2025, with the low at -$16.0 million in Q3 2021.
- The 5-year median for Profit After Tax is -$3.9 million (2021), against an average of -$4.3 million.
- The sharpest annual moves came in 2021 and 2025: Profit After Tax slumped 7188.94% in 2021, then soared 504.01% in 2025.
- Biofrontera's Profit After Tax stood at -$14.5 million in 2021, then surged by 80.8% to -$2.8 million in 2022, then soared by 226.61% to $3.5 million in 2023, then sank by 139.59% to -$1.4 million in 2024, then jumped by 504.01% to $5.6 million in 2025.
- Business Quant data shows BFRI's Profit After Tax at $5.6 million in Q4 2025, -$6.6 million in Q3 2025, and -$5.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Biofrontera | 18.35 Mn | 13.64 Mn | 9.59 Mn | -604,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -604,000.00 |
| Dec 31, 2025 | 5.64 Mn |
| Sep 30, 2025 | -6.65 Mn |
| Jun 30, 2025 | -5.32 Mn |
| Mar 31, 2025 | -4.20 Mn |
| Dec 31, 2024 | -1.40 Mn |
| Sep 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -257,000.00 |
| Mar 31, 2024 | -10.44 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | -6.34 Mn |
| Jun 30, 2023 | -9.84 Mn |
| Mar 31, 2023 | -7.48 Mn |
| Dec 31, 2022 | -2.79 Mn |
| Sep 30, 2022 | -2.57 Mn |
| Jun 30, 2022 | -850,000.00 |
| Mar 31, 2022 | 5.56 Mn |
| Dec 31, 2021 | -14.51 Mn |
| Sep 30, 2021 | -16.01 Mn |
| Jun 30, 2021 | -3.66 Mn |